The U.S. health regulator has authorized COVID-19 shots from Moderna and Pfizer and its partner BioNTech that target both the original coronavirus and Omicron sub-variants for use in children as young as six months of age.
U.S. FDA approves bivalent COVID-19 vaccines for kids as young as 6 months old